Tumour necrosis factor-alpha — Drug Target

All drugs that target Tumour necrosis factor-alpha — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

TNF-alpha inhibitor

Phase 1 pipeline (1)

• Adalimumab ID · Centre for Human Drug Research, Netherlands · TNF-alpha inhibitor · Immunology
  Tumour necrosis factor-alpha inhibitor